|
| | 
|
 | |
        
|  |
 
|
 SANOFI - [Ticker: SAN.PA] |     | | Last Trade | 80.53 | Last Trade Time | 2017-11-01 - 21:36:00 | | Variation | -0.76 (-0.93%) | Open | 81.79 | | High | 81.99 | Low | 80.43 | | Volume | 2,902,429 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 71.12 x 1,000 - 71.74 x 44,000 | | Former Close | 81.29 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about SANOFI: | | No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised. |
|
News about SANOFI [SAN.PA]: (ordered by relevance)
| | Sanofi MS Drug Shines in Phase 2, Paving Way for a Pivotal Test ... MedCity News
Sanofi announces positive data for frexalimab product to treat ... Reuters
Sanofi drug, acquired from a startup, shows early potential in MS BioPharma Dive
Exclusive: Affini-T taps Sanofi alum to lead hunt for partnerships ... Endpoints News
Press Release: Sanofi launches 2023 global Employee Stock Purchase Plan Yahoo Finance
Sanofi Reports Data Showing RSV Drug Protects Infants in Real ... MedCity News
Was This $3 Billion Deal a Wise Move for Sanofi? The Motley Fool
Gen Z needs brand-new skills to climb to the C-suite: ?What got me here will not get them there,? says health care CEO Fortune
Sanofi (SNY) Gains But Lags Market: What You Should Know Nasdaq
Sanofi seeks to build on COPD win Evaluate Pharma
Jessamy Baird of Sanofi named as new ABPI Vice-President Elect The Association of the British Pharmaceutical Industry
Fitch Upgrades Sanofi to 'AA-'; Outlook Stable Fitch Ratings
Sanofi (EPA:SAN) Stock Goes Ex-Dividend In Just Four Days Simply Wall St
Sanofi deploys Veeva Systems' solutions Pharmaceutical Technology
Sanofi is calling for a comprehensive, UK guideline to improve ... pharmaphorum
Supreme Court backs Sanofi in high-profile cholesterol drug suit ... Pharmaceutical Technology
Enablement Unchanged: Amgen v. Sanofi and the Future of ... JD Supra
Positive results for Sanofi/Regeneron?s Dupixent published in ... PMLiVE
Top Stock Reports for FEMSA, NextEra Energy & Sanofi Nasdaq
Sanofi and AstraZeneca's RSV antibody shows mettle in real-world ... Pharmaceutical Technology
LGBT Corporate Ally: At Sanofi, 'everyone has a right to express ... The Business Journals
SCOTUS rules unanimously in favor of Sanofi and Regeneron in ... Endpoints News
Heads up, Roche and Sanofi: Pfizer's hemophilia program notches ... MM+M Online
Roche?s multiple sclerosis win puts more pressure on Sanofi Evaluate Pharma
Sanofi CEO: ?Europe?s lead in life sciences R&D is eroding?but co-localized hubs could allow it to keep up? Yahoo Finance
Phase I completion of Sanofi?s vWD therapy demonstrates promise ... Pharmaceutical Technology
Sanofi research demonstrates 9.3% reduction in all-cause ... PR Newswire
Shaq's foundation team with Sanofi for Comebaq Court facility FiercePharma
Sanofi board approves demerger of its consumer healthcare business Economic Times
Eli Lilly CEO vows not to raise insulin prices again, while Novo Nordisk and Sanofi hedge CNBC
Sanofi Accelerates Beyond Standard Healthcare - Taiwan Business ... Taiwan Business TOPICS
Sanofi Canada's Dupixent receives approval to treat EoE Pharmaceutical Technology
5 Takeaways from the U.S. Supreme Court Decision in Amgen v ... Procopio
Form 6-K Sanofi For: Jun 02 StreetInsider.com
Cancer is becoming the leading cause of death in diabetes ... The Lancet
Auto Injectors Market Status and Prospects 2022 to 2032 | By Sanofi ... PharmiWeb.com
Victory Capital Management Inc. Boosts Holdings in Sanofi, a Top ... Best Stocks
Sensex rises 100 points, Nifty tops 18,300; Sanofi jumps 3% Economic Times
Global Multiple Sclerosis Clinical Trial Analysis 2023 Update ... Business Wire
After price cuts, Eli Lilly inks $13.5M settlement in long-running ... FiercePharma
Diabetic Kidney Disease Market expected to rise, AstraZeneca ... Digital Journal
Global Injection Pen Market Report 2023: Major Players Include Novo Nordisk, Ypsomed Holding, Sanofi, Eli Lilly and Company and Merck KGaA Mumford, Yahoo Finance UK
Amyotrophic Lateral Sclerosis Market to Witness Growth by 2032 ... Digital Journal
Coherus Biosciences Joins Forces With Mark Cuban's Online ... Drug Topics
Rabies Vaccine Market Growth Opportunity : GSK (Novartis), Sanofi ... SleterFC.com
Anti-wrinkle Products Market Recent Trends, In-depth Analysis, Size ... Digital Journal
Efficient and Profitable: Global Enoxaparin Market Outlook 2023 ... SleterFC.com
Pharma Stock Roundup: FDA Okays PFE RSV Jab for Elderly, AZN Ends Brazikumab Studies Yahoo Finance
Low Molecular Weight Heparin Market Product Scope ? Aspen ... SleterFC.com
Edward's Syndrome Treatment Market Share 2023 to 2033 | By ... Digital Journal
Allergy Care Market Massive Growth opportunity Ahead ... SleterFC.com
Global Travel Vaccines Market Size and Forecast | Pfizer, Sanofi ... SleterFC.com
Smart Insulin Pens Market Forecast to 2031 | By Companion ... Future Market Insights
Preventive Vaccines Market Analysis With The Market Scenario ... Digital Journal
Roche's Fenebrutinib Pulls Ahead in the BTK Inhibitor Race Managed Healthcare Executive
Go or no go? Key FDA decisions for Argenx and Regeneron Evaluate Pharma
Global Healthcare Nanotechnology (Nanomedicine) Market Size ... SleterFC.com
Fifth Annual Best of Benchmark Award Winners Announced Business Wire
Skin Fibrosis Treatment Market Growth Factors,Types and ... Digital Journal
Infinity merger with MEI in doubt after surprise buyer makes bid FierceBiotech
Highest dividend-yield mid-cap shares: Oil India, Sanofi, ICICI Sec, HPCL, Torrent Power, more The Financial Express
Kidney Transplant Market Growth and Analysis ? Industry Trends ... Digital Journal
Clinical Laboratory Service Market will grow due to increasing ... Digital Journal
Farallon says it's won all desired board seats from Exelixis after ... Endpoints News
Study offers the most comprehensive archive of cellular, molecular ... News-Medical.Net
Anticoagulant Market Analysis, Size, Growth, Revenue, Demand ... Digital Journal
Sanofi Finds Way to Maze Therapeutics to Get Its Next Pompe ... MedCity News
Sanofi vaccine: what to know about this protein-based COVID ... Gavi, the Vaccine Alliance
Sanofi Pasteur COVID-19 vaccine authorised by MHRA GOV.UK
New Mechanism Under Study for Relapsing MS May Offer Novel ... Neurology Live
Sanofi trade union network building constructive relationship with ... IndustriALL Global Union
After FDA Miss in Diabetes, Lexicon Lands Long-Awaited Approval ... MedCity News
Update to contractual arrangements between AstraZeneca, Swedish ... AstraZeneca
Global Diabetes Drugs Market By Type, Component, Industry ... SleterFC.com
Zika Virus Market Size, Share, Growth & Trends, Analysis by 2029 | Top Players: Cerus, Inovio Pharmaceuticals openPR
UK at risk of losing healthcare innovation race with European rivals ... Financial Times
Sanofi to cut US price of its most-prescribed insulin by 78% Reuters
Global Thin Film Drugs Market Status and Future, Geography ... SleterFC.com
Sanofi CEO: We Don't Have a Leaky Bathtub MedCity News
Product Information Leaflet (PIL) for VidPrevtyn Beta dispersion for ... GOV.UK
Hyaluronic Acid Based Dermal Fillers Market 2023 Company ... SleterFC.com
Trends and Forecast of the Global Pharma & Cosmetics Market ... SleterFC.com
Positive results for Sanofi?s haemophilia therapy published in The ... PMLiVE
Global Yellow Fever Treatment Market Size, Share, Forecast 2021 - 2030 | Key Players : Sanofi Pasteur SA, Jans openPR
Sanofi back on M&A trail with $2.9B deal for Provention FiercePharma
Sanofi's Provention buy hit with FTC delay FiercePharma
Sanofi begins construction of another flu vaccine plant FiercePharma
Peptide Therapeutics in Metabolic Disorders Market: Analysis of ... Digital Journal
Sanofi exec jumps to Owkin to ramp up the AI biotech's pharma ... MedCity News
Sanofi and Haleon to work towards petroleum-free consumer health ... Packaging Europe
Sanofi and Regeneron face a high-risk test for Dupixent Evaluate Pharma
Sanofi reports positive new data for multiple sclerosis treatment ... PMLiVE
Metastatic Prostate Cancer Pipeline: A Roadmap to Potential ... Digital Journal
COPD nod could be worth $3.5B for Sanofi, Regeneron's Dupixent FiercePharma
Sanofi looks to offload consumer business in India FiercePharma
Sanofi and Regeneron's Dupixent comes up big in COPD trial FiercePharma
Class 2 Medicines Recall: Aventis Pharma Limited (t/a Sanofi ... GOV.UK
With big launches on tap, Sanofi CEO Paul Hudson touts company's ... FiercePharma
Sanofi Inks Another AI Alliance, This Time Partnering With Insilico ... MedCity News
Sanofi announces change in R&D leadership Science Business
| For more news about SANOFI click here:
SANOFI News |
|
Website Width:
Background image: |
|  | |
|
|
![SANOFI - [Ticker: SAN.PA] chart](http://www.tr4der.com/chart/tr4der-SAN.PA-10-years.png)
